BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu S, Feng Y, He W, Xu W, Xu W, Yang H, Li X. Celastrol in metabolic diseases: Progress and application prospects. Pharmacol Res 2021;167:105572. [PMID: 33753246 DOI: 10.1016/j.phrs.2021.105572] [Cited by in Crossref: 5] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Tang YW, Yang RC, Wan F, Tang XL, Zhang HQ, Lin Y. Celastrol attenuates renal injury in 5/6 nephrectomized rats via inhibiting epithelial-mesenchymal transition and transforming growth factor-β1/Smad3 pathway. Exp Biol Med (Maywood) 2022;:15353702221118087. [PMID: 36046983 DOI: 10.1177/15353702221118087] [Reference Citation Analysis]
2 Li Z, Zhou KW, Chen F, Shang F, Wu MX. Celastrol inhibits laser-induced choroidal neovascularization by decreasing VEGF induced proliferation and migration. Int J Ophthalmol 2022;15:1221-30. [PMID: 36017049 DOI: 10.18240/ijo.2022.08.01] [Reference Citation Analysis]
3 Li Z, Zhang J, Duan X, Zhao G, Zhang M. Celastrol: A Promising Agent Fighting against Cardiovascular Diseases. Antioxidants 2022;11:1597. [DOI: 10.3390/antiox11081597] [Reference Citation Analysis]
4 Guo L, Qu B, Song C, Zhu S, Gong N, Sun J. Celastrol attenuates 6-hydroxydopamine-induced neurotoxicity by regulating the miR-146a/PI3K/Akt/mTOR signaling pathways in differentiated rat pheochromocytoma cells. J Affect Disord 2022;316:233-42. [PMID: 35981627 DOI: 10.1016/j.jad.2022.08.026] [Reference Citation Analysis]
5 Wang SW, Lan T, Zheng F, Huang H, Chen HF, Wu Q, Zhang F. Celastrol inhibits TXNIP expression to protect pancreatic β cells in diabetic mice. Phytomedicine 2022;104:154316. [PMID: 35820305 DOI: 10.1016/j.phymed.2022.154316] [Reference Citation Analysis]
6 Niu K, Bai P, Yang B, Feng X, Qiu F. Asiatic acid alleviates metabolism disorders in ob/ob mice: mechanistic insights. Food Funct 2022. [PMID: 35696250 DOI: 10.1039/d2fo01069k] [Reference Citation Analysis]
7 Liu J, Guo X, Yang L, Tao T, Cao J, Hong Z, Zeng F, Lu Y, Lin C, Qin Z. Effect of Celastrol on LncRNAs and mRNAs Profiles of Cerebral Ischemia-Reperfusion Injury in Transient Middle Cerebral Artery Occlusion Mice Model. Front Neurosci 2022;16:889292. [DOI: 10.3389/fnins.2022.889292] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Luo P, Zhang Q, Zhong TY, Chen JY, Zhang JZ, Tian Y, Zheng LH, Yang F, Dai LY, Zou C, Li ZJ, Liu JH, Wang JG. Celastrol mitigates inflammation in sepsis by inhibiting the PKM2-dependent Warburg effect. Mil Med Res 2022;9:22. [PMID: 35596191 DOI: 10.1186/s40779-022-00381-4] [Reference Citation Analysis]
9 Fan N, Zhao J, Zhao W, Zhang X, Song Q, Shen Y, Shum HC, Wang Y, Rong J. Celastrol-loaded lactosylated albumin nanoparticles attenuate hepatic steatosis in non-alcoholic fatty liver disease. J Control Release 2022;347:44-54. [PMID: 35483638 DOI: 10.1016/j.jconrel.2022.04.034] [Reference Citation Analysis]
10 Luo P, Liu D, Zhang Q, Yang F, Wong YK, Xia F, Zhang J, Chen J, Tian Y, Yang C, Dai L, Shen HM, Wang J. Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1. Acta Pharm Sin B 2022;12:2300-14. [PMID: 35646542 DOI: 10.1016/j.apsb.2021.12.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
11 Fan N, Zhao J, Zhao W, Shen Y, Song Q, Shum HC, Wang Y, Rong J. Biodegradable celastrol-loaded albumin nanoparticles ameliorate inflammation and lipid accumulation in diet-induced obese mice. Biomater Sci 2022. [PMID: 35019905 DOI: 10.1039/d1bm01637g] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Xu S, Fan R, Wang L, He W, Ge H, Chen H, Xu W, Zhang J, Xu W, Feng Y, Fan Z. Synthesis and biological evaluation of celastrol derivatives as potent antitumor agents with STAT3 inhibition. J Enzyme Inhib Med Chem 2022;37:236-51. [PMID: 34894961 DOI: 10.1080/14756366.2021.2001805] [Reference Citation Analysis]
13 Wu Q, Wang J, Wang Y, Xiang L, Tan Y, Feng J, Zhang Z, Zhang L. Targeted delivery of celastrol to glomerular endothelium and podocytes for chronic kidney disease treatment. Nano Res 2021;:1-13. [PMID: 34925707 DOI: 10.1007/s12274-021-3894-x] [Reference Citation Analysis]
14 Xu S, Lyu L, Zhu H, Huang X, Xu W, Xu W, Feng Y, Fan Y. Serum Metabolome Mediates the Antiobesity Effect of Celastrol-Induced Gut Microbial Alterations. J Proteome Res 2021;20:4840-51. [PMID: 34530620 DOI: 10.1021/acs.jproteome.1c00513] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
15 Ajmal M, Ajmal A, Huang L, Zeng L. The Potential Therapeutic Role of Celastrol in Patients With Heart Failure With Preserved Ejection Fraction. Front Cardiovasc Med 2021;8:725602. [PMID: 34490381 DOI: 10.3389/fcvm.2021.725602] [Reference Citation Analysis]
16 Liu DD, Luo P, Gu L, Zhang Q, Gao P, Zhu Y, Chen X, Guo Q, Zhang J, Ma N, Wang J. Celastrol exerts a neuroprotective effect by directly binding to HMGB1 protein in cerebral ischemia-reperfusion. J Neuroinflammation 2021;18:174. [PMID: 34372857 DOI: 10.1186/s12974-021-02216-w] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
17 Fan Q, Xu F, Liang B, Zou X. The Anti-Obesity Effect of Traditional Chinese Medicine on Lipid Metabolism. Front Pharmacol 2021;12:696603. [PMID: 34234682 DOI: 10.3389/fphar.2021.696603] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
18 Xu Q, Chen G, Xu H, Xia G, Zhu M, Zhan H, Zhang B, Dai M, Fan H, Liu X. Celastrol Attenuates RANKL-Induced Osteoclastogenesis in vitro and Reduces Titanium Particle-Induced Osteolysis and Ovariectomy-Induced Bone Loss in vivo. Front Pharmacol 2021;12:682541. [PMID: 34149427 DOI: 10.3389/fphar.2021.682541] [Cited by in F6Publishing: 1] [Reference Citation Analysis]